Product Description
Utilizing wireless wearable sensors, MC10 BiostampRC, to capture quantitative biometric and movement-based data. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT04219670)
Mechanisms of Action: Device
Novel Mechanism: No
Modality: Device
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Australia | Canada | Chile | Colombia | Dominican Republic | India | United Arab Emirates
Approved Indications: None
Known Adverse Events: None
Company: Emyria
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|
| Emerald-NRAD | N/A |
Unknown status |
Alzheimer Disease|Cognitive Dysfunction |
2025-04-30 |
2025-05-03 |
Primary Endpoints|Treatments|Trial Status |
|
| OPAL | N/A |
Completed |
Parkinson's Disease |
2024-05-07 |
2024-06-28 |
Primary Completion Date|Primary Endpoints|Study Completion Date|Treatments|Trial Status |
|
| EMERALD | N/A |
Completed |
Adenocarcinoma|Esophagitis|Barrett Esophagus|Esophageal Cancer|Gastroesophageal Reflux|Gastrointestinal Cancer |
2024-04-24 |
2024-05-11 |
Primary Endpoints |
|
| SENS-101-RSRT | N/A |
Completed |
Rett Syndrome |
2023-03-01 |
2023-03-29 |
Patient Enrollment|Primary Completion Date|Primary Endpoints|Study Completion Date|Treatments|Trial Status |
|
| Prognostic factors in CLL | N/A |
Unknown status |
Chronic Lymphoid Leukemia |
2022-09-01 |
2023-10-03 |
Primary Endpoints|Treatments|Trial Status |
|
| H-35364 | N/A |
Completed |
Parkinson's Disease |
2018-07-01 |
2019-03-21 |
Study Completion Date|Treatments|Trial Status |
|
| EMERALD | N/A |
Unknown status |
Obesity |
2017-07-01 |
2019-03-19 |
Treatments |
|
| EMERALD | N/A |
Completed |
Type 2 Diabetes|Weight Gain|Obesity, Morbid|Diabetes Complications|Depressive Disorder |
2017-02-01 |
2022-04-01 |
Patient Enrollment|Primary Completion Date|Primary Endpoints|Start Date|Study Completion Date|Treatments |
|
| ChiCTR1800014833 | N/A |
Completed |
Pigmentation Disorders|Hyperpigmentation |
2016-11-30 |